Featured Post
Why Automation Is Growing in Non-Sterile Compounding in the USA
Non-sterile compounding automation is reshaping how independent pharmacies in the United States operate. Driven by a convergence of regulatory demands, workforce constraints, and rising patient demand for personalized dosing, compounding pharmacy automation has moved from a niche consideration to a strategic priority for private pharmacies looking to remain competitive and compliant in 2026 and beyond.
CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
CurifyLabs Raises $14M Series A to Power the Future of Personalized Medicine
Gold at the iF Design Awards — and what it really means for us
CurifyLabs wins iF Design Award 2026 Gold for its blister solution — recognised for real-world impact on personalised medicine, usability, and patient safety.
CurifyLabs in a Podcast Episode by the Pharmacy Podcast Network
Listen to the latest episode of the Pharmacy Podcast Network with CurifyLabs.
.svg)
CurifyLabs Wins Red Dot: Best of the Best for PharmaPrinter Aurum
CurifyLabs Wins Red Dot: Best of the Best for PharmaPrinter Aurum
CurifyLabs Position Paper
CurifyLabs reviews the EMA's Q&A on 3D printing in pharmaceuticals, emphasizing quality standards and the need for robust systems in pharmacy compounding.
Press Release: CurifyLabs Launches Next-Generation Compounding Software to Advance Personalized Medicine
CurifyLabs launches advanced compounding software, enhancing 3D printing technology for hospitals and pharmacies to deliver faster, safer, and more personalized medication solutions.
Quality of CurifyLabs’ Compounding System Solution Validated by Independent Laboratories
Quality of CurifyLabs’ Compounding System Solution Validated by Independent Laboratories: Ensuring Stability and Compliance of Pharmacy-Compounded Personalised Medicines
CurifyLabs’ Technology Validated in European-Wide Study
CurifyLabs peer reviewed article, Delpech Paris, Charite, Helios, Lausanne University Hospital, Mainz University Hospital